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Background: Kawasaki disease (KD) without affection of the coronary artery system is rare. Optic nerve pathology
together with KD has not been described earlier.
Case presentation: We present one case of KD in a 12-year-old girl predominantly with prolonged cholestasis, and
a second case of multiple recurrent KD in a 9-year-old boy with hepatomegaly and ischemic optic nerve
neuropathy. The coronary artery system was not involved in either case.
Conclusions: KD warrants rapid diagnosis and immediate specific treatment in order to prevent the high risk of
coronary artery aneurysm and stenosis.
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Various manifestations of Kawasaki disease (KD) occur at
an early age. When the hepatobiliary tract is primarily
affected, the diagnosis relies mainly on symptoms, ultra-
sonography and laboratory parameters of systemic vascu-
litis. Numerous diseases must be excluded. Incomplete
and atypical cases are difficult to detect. Rapid diagnosis
and treatment are crucial, as 4 % of KD patients develop
coronary artery (CA) involvement [1].
Case presentation
Case 1
A 12-year-old girl presented with a 6-day history of
subfebrile temperature, generalized lymphadenitis, fatigue
and inappetence. Exanthema of the extremities and trunk,
raspberry tongue, bulbar injection, facial edema, palmar
erythema, swelling of the small-finger joints, discrete
jaundice and epigastric tenderness were observed. The gen-
eral practitioner (GP) had treated her (benzathin-phenoxy-
methyl penicillin, 750 mg TID) for suspected scarlet fever.
Laboratory data (and normal range in parenthesis) were:
WBCC 15 400/mm3 (4 500–12 000/mm3), PMN cells
73.4 % (50.0–75.0 %), lymphocytes 9.4 % (20.0–40.0 %),
eosinophils 9.0 % (0–5.0 %), platelets 451 000/mm3 (140
000–440 000/mm3), CRP 15 mg/l (0–8 mg/l), ASL 971U/* Correspondence: ingeborg.keeling@medunigraz.at
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(http://creativecommons.org/publicdomain/zeml (0–125U/ml), total bilirubin 5.37 mg/dl (0–1.30 mg/
dl), esterized bilirubin 2.86 mg/dl (<0.20 mg/dl), ASAT
17U/l (0–21U/l), ALAT 42U/l (0–22U/l), GGT 50U/l (0–
19U/l), AP 557U/l (0–390U/l), HDL cholesterol 5 mg/dl
(≥37 mg/dl), bilirubinuria, and ketonuria. Hepatitis
screening revealed borderline complement binding reac-
tion for Enterovirus and Coxsackievirus types other than
A9. The chest x-ray showed prominent hila and the ECG
a normofrequent sinus rhythm. Echocardiography indi-
cated normal left ventricular function. CAs had normal
dimension, no signs of aneurysm. Liver ultrasonography
revealed distinct periportal fields. Clinical symptoms
suggested KD with uncommon cholestasis. On the day of
admission, treatment was started with intravenous immune
globulin (IVIG) (Octagam®, 1.6 g/kg/d), aspirin (ASA,
500 mg TID), sucralfate (1 g TID), and ursodeoxycholic
acid (100 mg TID).
Desquamation of the fingertips and pronounced
jaundice developed. The blunt liver margin was palpated
0.5–1 cm underneath the right costal edge and hepatic
consistency was found normal. Moderately acholic stools
and hyperchromic urines were noted. Ultrasonography
and MRI showed hepatomegaly (13x16x9.6 cm) and regu-
lar width of intra- and extrahepatic bile ducts. After
10 days, the patient improved and was discharged with
ASA treatment.
Immunologic screening revealed positive anti-Ro-antibodies
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charge, transaminases and platelet counts normalized while
total cholesterol (249 mg/dl, normal <200 mg/dl) and
eosinophils (11.1 %, normal 0–5.0 %) remained elevated.
Case 2
Since his fourth month of life, a 9-year-old boy experi-
enced upper respiratory infections and recurrent otitis.
At the age of 4 years he was admitted 5 days after head-
aches, conjunctival injection, fever, fatigue, enanthema of
the throat and tonsils, raspberry tongue and enlargement
of submandibular lymph nodes evolved. Laboratory re-
sults were: WBCC 27 300/mm3, (4 500–12 000/mm3),
platelets 594 999/mmm3 (140 000–440 000/mm3), CRP
25 mg/l (0–8 mg/l), ESR 60/96 (3–13 mm/1 h), ASL and
RF negative. Although an exanthema was missing, clinical
findings suggested incomplete KD. Treatment consisted
of IVIG (Octagam®, 2 g/kg/d), and high-dose ASA
(300 mg QID) for 3 weeks. Fever resolved within 24 h.
Desquamation of the toes developed upon discharge.
After persistent fever for 10 days at age 6 years, resist-
ant to antibiotic treatment occurred along with repeated
vomiting, fatigue, angina, headaches, photophobia, rasp-
berry tongue and desquamation of the toes. Laboratory
data were: WBCC 21 800/mm3, platelets 746 000/mm3,
CRP 22 mg/l, ESR 110 mm/1 h. Recurrent incomplete
KD was diagnosed. The child developed intolerance to
IVIG (Endobulin®, 5 g), with severe abdominal pains.
The liver margin was palpable 0.5 cm below the right
costal edge, hepatic consistency was normal. Stool and
urine were unremarkable. Only once during the hospital
stay ASAT 26U/l (0–21U/l) and ALAT 23U/l (0–22U/l)
were slightly elevated. CT showed hepatomegaly, a prom-
inent, homogenous pancreas, and reflections, possibly
small sedimentations, in the choledochus duct. The exam-
ination neither confirmed nor dismissed an autoimmune
disease. Reduced tissue necrosis factor (TNF)–receptor
levels (0.81 ng/ml; 50 % of the minimum norm) suggested
autosomal-dominant TNF-receptor associated periodic
fever syndrome (TRAPS), but exon 2–5 mutations of the
TNFR1A1 gene were not found in PCR.
At the age of 9 years the patient was admitted for acute
right-sided ablepsia. The ophthalmologist diagnosed ische-
mic optic nerve neuropathy. High-dose steroids for 13 days
incompletely restored the child’s vision. The examination
for an autoimmunologic disease was negative.
Conclusions
In both exposed cases, KD was strongly suggested at
admission. Uncommon clinical features in these two chil-
dren were hepatopathy, cholestasis and diarrhea. In case 1,
hepatomegaly and cholestasis, with distinct periportal
fields, were identified by ultrasonography and MRI. In case
2, hepatomegaly with cholangitis was present. The CAsystem was unaffected. The predominant gastrointestinal
manifestation in up to 13.9 % of KD cases is acalculous
gallbladder hydrops, which may require cholecystectomy
or percutaneous transhepatic biliary drainage [2]. Hepato-
pathy exceptionally rarely induces hepatocellular necrosis
[3]. Other manifestations include hepatitis, pancreatitis,
enteritis and ileus. Gilbert’s syndrome with concurrent in-
fection may resemble KD in clinical terms.
Childhood diseases like scarlet fever may manifest
symptoms of hepatopathy and cholestasis. Coxsackievirus
and Enterovirus associated hepatopathy were unlikely, as
cholestasis without hepatitis, and elevated ESR and PMN
are usually unrelated to these viral infections. In any case,
KD-related macrophage activation syndrome (MAS)
should be also suspected if liver dysfunction presents with
other typical abnormal laboratory findings, such as cyto-
penia, hyperferritinemia and elevated serum LDH.
Initial antibiotic treatment for suspected bacterial
infection, as in the present case, renders drug side-
effects an important differential diagnosis. In case 1,
where positive Ro-antibodies, extractable nuclear antigen-
ribonucleoprotein (U1-snRNP), and elevated eosinophils
suggested autoimmune hepatopathy rather than penicillin
reaction, jaundice subsided without treatment 5 weeks
post-discharge.
Toxic shock syndrome (TSS) may mimic KD. A
connection between staphylococcal and streptococcal
TTS and KD has also been suggested [1].
Specific immunologic alterations may be found in KD,
which requires extensive immunologic testing and the use
of image processing to confirm KD diagnosis. Therefore,
in complex KD cases multispecialist approach, including
the pediatric cardiologist, immunologists, rheumatologist,
hepatologist, infectiologist, ophthalmologist, intensive care
personnel, and clinical pharmacologist, are essential to
avoid the many pitfalls of rapid diagnosis.
KD patients with fever, CRP >10 mg/dl, LDH >590U/l
and/or hemoglobin <10 g/dl, and those with high biliru-
bin and transaminases, are considered non-responsive to
IVIG [4]. IVIG resistance with persistent or recrudescent
fever occurs in approximately 18 % of KD patients.
Retreatment involved more individual adjustment, con-
sisting of intravenous steroid pulse therapy, infliximab,
cyclophosphamide, anakinra, etanercept, methotrexate,
or plasmapheresis [1, 4–6]. Additionally, antioxidants, as
vitamin C, and drugs affecting cholesterol levels, can
reduce endothelial dysfunction.
Abnormalities of liver function tests are frequently
found in patients with acute KD. Indeed, children with
abnormal liver function tests are at higher risk for IVIG
resistance [7, 8]. Moreover, ultrasonographic biliary find-
ings or higher AST levels may be risk factors for coronary
artery abnormality as a complication and/or recurrent KD
if they are present during the first episode [9, 10].
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tremely rare ophthalmologic KD manifestation, specifically
ischemic optic nerve neuropathy, which to our knowledge
is the first reported case of optic nerve pathology associated
with KD [11]. However, transient affliction of the cranial
nerves may at times be either the presenting feature or a
complication of an otherwise uncomplicated KD in infants
and children. Oculomotor nerve palsy may resolve after
IVIG therapy [12].
In conclusion, atypical KD calls for extreme alert-
ness, rapid diagnosis and immediate treatment if sug-
gested. The absence of CA lesions and the presence of
cholestasis may delay the diagnosis and specific treat-
ment of this potentially life-threatening disease with
severe long-term consequences.
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